Sunflower Pharmaceuticals Group Co Ltd Strategic Asset Allocation Index
Sunflower Pharmaceuticals Group Co Ltd strategic asset allocation index. Sunflower Pharmaceuticals Group Co Ltd (002737) has a Strategic Asset Allocation Index of 30.2% as of September 2023. Strategic assets (PP&E of CN¥1.43 Billion plus long-term investments of CN¥-) total CN¥1.43 Billion, measured against net assets of CN¥4.72 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Sunflower Pharmaceuticals Group Co Ltd's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Sunflower Pharmaceuticals Group Co Ltd (2011–2022)
Strategic asset allocation index of Sunflower Pharmaceuticals Group Co Ltd from 2011 to 2022. This chart shows how Sunflower Pharmaceuticals Group Co Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of September 2023, the index stands at 30.2%, representing strategic assets of CN¥1.43 Billion against net assets of CN¥4.72 Billion CNY. Check 002737 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Sunflower Pharmaceuticals Group Co Ltd Strategic Asset Allocation Index by Year (2011–2022)
Sunflower Pharmaceuticals Group Co Ltd strategic asset allocation index by year from 2011 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Sunflower Pharmaceuticals Group Co Ltd from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 002737 market cap overview.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 33.7% | CN¥1.50 Billion | CN¥1.50 Billion | CN¥- | CN¥4.44 Billion | ▼ -6.4 pp |
| 2021 | 40.1% | CN¥1.58 Billion | CN¥1.58 Billion | CN¥- | CN¥3.94 Billion | ▼ -7.4 pp |
| 2020 | 47.4% | CN¥1.61 Billion | CN¥1.61 Billion | CN¥- | CN¥3.39 Billion | ▲ +3.1 pp |
| 2019 | 44.3% | CN¥1.52 Billion | CN¥1.52 Billion | CN¥- | CN¥3.43 Billion | ▲ +5.6 pp |
| 2018 | 38.8% | CN¥1.33 Billion | CN¥1.33 Billion | CN¥2.86 Million | CN¥3.44 Billion | ▼ -1.1 pp |
| 2017 | 39.9% | CN¥1.26 Billion | CN¥1.26 Billion | CN¥3.02 Million | CN¥3.16 Billion | ▼ -3.7 pp |
| 2016 | 43.6% | CN¥1.22 Billion | CN¥1.22 Billion | CN¥1.75 Million | CN¥2.80 Billion | ▼ -3.5 pp |
| 2015 | 47.1% | CN¥1.23 Billion | CN¥1.23 Billion | CN¥1.75 Million | CN¥2.61 Billion | ▲ +6.7 pp |
| 2014 | 40.4% | CN¥919.86 Million | CN¥919.86 Million | CN¥- | CN¥2.28 Billion | ▼ -47.0 pp |
| 2013 | 87.3% | CN¥759.02 Million | CN¥759.02 Million | CN¥- | CN¥869.02 Million | ▲ +7.6 pp |
| 2012 | 79.8% | CN¥605.12 Million | CN¥605.12 Million | CN¥- | CN¥758.39 Million | ▼ -16.0 pp |
| 2011 | 95.8% | CN¥520.62 Million | CN¥520.62 Million | CN¥- | CN¥543.47 Million | — |